Custom prototypes maker Proto Labs beats Q3 profit estimates on bigger contracts

Reuters
2025/10/31
Custom prototypes maker Proto Labs beats Q3 profit estimates on bigger contracts

Overview

  • Proto Labs Q3 revenue grows 7.8% yr/yr, beating analyst expectations

  • Adjusted EPS for Q3 beats consensus, reflecting strong operational performance

Outlook

  • Company expects Q4 2025 revenue between $125.0 mln and $133.0 mln

  • Company sees Q4 2025 diluted EPS between $0.12 and $0.20

  • Company expects Q4 2025 non-GAAP EPS between $0.30 and $0.38

Result Drivers

  • PROTOLABS NETWORK - Revenue from the Protolabs Network increased 19.1% yr/yr, contributing to overall revenue growth

  • CUSTOMER ENGAGEMENT - Revenue per customer contact increased 14.1% yr/yr, indicating improved customer engagement

  • STRATEGIC FOCUS - Co's strategy of delivering high-quality, custom parts throughout the product lifecycle supported growth

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$135.36 mln

$133.83 mln (5 Analysts)

Q3 Adjusted EPS

Beat

$0.47

$0.39 (5 Analysts)

Q3 Adjusted Net Income

Beat

$11.40 mln

$9.40 mln (4 Analysts)

Q3 Net Income

$7.21 mln

Q3 Gross Profit

$61.29 mln

Q3 Operating Expenses

$52.48 mln

Q3 Operating Income

$8.81 mln

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the industrial machinery & equipment peer group is "buy"

  • Wall Street's median 12-month price target for Proto Labs Inc is $51.00, about 4% below its October 30 closing price of $53.03

  • The stock recently traded at 34 times the next 12-month earnings vs. a P/E of 27 three months ago

Press Release: ID:nBw7g6MpKa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10